Related posts

Most Anticipated Earnings: IAG-T, BDT-T and more Canadian Companies Reporting Earnings this Week (Nov 04-08)Most Anticipated Earnings: MRE-T, PSI-T and more Canadian Companies Reporting Earnings this Week (Aug 05-09).Most Anticipated Earnings: BLDP-T, BOS-T and more Canadian Companies Reporting Earnings this Week (May 06-10)
Investor Insights

This summary was created by AI, based on 2 opinions in the last 12 months.

DRI Healthcare Trust, symbol DHT.UN-T, is utilizing an innovative royalty approach adapted from the mining sector for the pharmaceutical industry. This capital-light business structure affords it the flexibility to foster new developments within pharmaceuticals, setting it apart in a rapidly evolving market. With the second listing of this nature globally, the stock is currently trading at approximately 1.3 times its book value, which experts consider to be very cheap. Additionally, the stock is exhibiting an uptrend, despite experiencing a pullback which suggests a healthy correction. The technical analysis indicates that the stock is still maintaining its trend lines, bolstering its long-term investment appeal.

Consensus
Positive
Valuation
Undervalued
TOP PICK

Applied similar royalty approach from mining sector to pharmaceutical business. Allows for new development in pharmaceutical business. Capital light business. Second listing in the world of this nature. Very cheap valuation, trading ~1.3x book value. Excellent long term prospects. 

BUY

In an uptrend, testing the trendline. From the chart, you can see how it arced too high and now it's going through a pullback. The trend is still in place. So far, it looks fine technically. 

DON'T BUY
Too small for him, challenging environment. Management seems solid. Invests in biotech and pharma companies in exchange for a royalty. Drugs are coming off patent, so revenues will decline. Check out the payout ratio. He tracks RPRX in the US, which is 100x bigger with 25B market cap.
COMMENT

Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. The royalty focus and the sector is interesting. The stock has done well following its public debut a month ago at $10. The company seems to be well managed and there is a good story and potential. Unlock Premium - Try 5i Free

Showing 1 to 4 of 4 entries
  • «
  • 1
  • »

DRI Healthcare Trust(DHT.UN-T) Rating

Ranking : 4 out of 5

Star iconStar iconStar iconStar iconStar empty icon

Bullish - Buy Signals / Votes : 1

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 1

Stockchase rating for DRI Healthcare Trust is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

DRI Healthcare Trust(DHT.UN-T) Frequently Asked Questions

What is DRI Healthcare Trust stock symbol?

DRI Healthcare Trust is a OTC stock, trading under the symbol DHT.UN-T on the (). It is usually referred to as or DHT.UN-T

Is DRI Healthcare Trust a buy or a sell?

In the last year, 1 stock analyst published opinions about DHT.UN-T. 1 analyst recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for DRI Healthcare Trust.

Is DRI Healthcare Trust a good investment or a top pick?

DRI Healthcare Trust was recommended as a Top Pick by on . Read the latest stock experts ratings for DRI Healthcare Trust.

Why is DRI Healthcare Trust stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is DRI Healthcare Trust worth watching?

1 stock analyst on Stockchase covered DRI Healthcare Trust In the last year. It is a trending stock that is worth watching.

What is DRI Healthcare Trust stock price?

On , DRI Healthcare Trust (DHT.UN-T) stock closed at a price of $.